Recombinant protein drugs

Recombinant proteins can be efficiently expressed in systems such as E. coll, yeast, insect, and mammalian cells, and their expression generally includes extracellular secretory expression, intracellular soluble expression, and intracellular insoluble expression (where the product is in the form of inclusion bodies).

Recombinant protein drugs
are drugs that use genetic engineering techniques to modify “engineered bacteria” or “engineered cells” to express human functional proteins or their mutants in bulk to compensate for the absence of corresponding functional proteins in the body due to congenital genetic defects or acquired diseases. Therapeutic recombinant protein drugs include cytokines, monoclonal antibodies, fusion proteins, hormones, and enzymes, etc., which are produced by recombinant DNA expression technology and injected to exert therapeutic effects in the body.

With the development of genetics, genomics, proteomics, and basic medicine, the market demand for recombinant functional proteins has increased dramatically, and Creative BioMart is the world’s preeminent recombinant protein manufacturer, offering several hundred lines of recombinant protein products and several scarce human-derived protein products. Strict quality control guarantees industry-leading bioactivation and batch-to-batch consistency of our protein products, enhancing confidence in results and ensuring reproducibility.

Recombinant protein drugs